Here's What Key Metrics Tell Us About Nutanix (NTNX) Q4 Earnings

Nutanix (NTNX) reported strong Q4 2025 results, with revenue of $653.27 million, up 19.2% year-over-year, and EPS of $0.37, both surpassing consensus estimates by 1.63% and 15.63% respectively. The company also exceeded expectations for total billings and several revenue segments, notably non-portable software revenue which surged 393.8% year-over-year, though Annual Recurring Revenue (ARR) of $2.22 billion slightly missed analyst projections. Despite these operational beats, NTNX shares have declined 9.9% over the past month, underperforming the broader S&P 500.

Analysis

Nutanix reported strong Q4 2025 results, decisively surpassing Wall Street expectations on both revenue and earnings. Revenue grew 19.2% year-over-year to $653.27 million, a 1.63% surprise, while EPS of $0.37 represented a significant 15.63% beat over the consensus estimate of $0.32. This performance was supported by beats across most operating metrics, including total billings which reached $726.89 million against an estimate of $721.33 million. Growth was notably strong in product revenue, up 27.8% year-over-year, and subscription revenue, up 18.8%. However, a critical point of concern is the slight miss on Annual Recurring Revenue (ARR), which came in at $2.22 billion versus an estimate of $2.23 billion. Despite the otherwise strong operational report, the company's stock has notably underperformed, declining 9.9% over the past month in contrast to the S&P 500's 1.3% gain. This divergence suggests the market may be weighing the ARR miss more heavily than the headline beats, a sentiment reflected in the neutral Zacks Rank #3 (Hold) rating.

Key Decisions for Investors

• Investors should scrutinize the slight miss in Annual Recurring Revenue (ARR), as this key forward-looking metric for subscription models may be the primary driver of the recent stock underperformance despite the headline earnings beat.
• The significant disconnect between the strong quarterly results, including a 15.63% EPS surprise, and the stock's recent 9.9% decline warrants caution; traders should investigate whether this reflects a buying opportunity or underlying concerns about future guidance not covered in this report.
• Given the conflicting signals of a strong operational beat against a slight ARR miss and negative market reaction, maintaining a neutral stance in line with the Zacks #3 (Hold) rating and monitoring future ARR trends is a prudent strategy.